[EFFECT] KalVista Pharmaceuticals, Inc. SEC Filing Filing Impact (Neutral) Filing Sentiment (Neutral) Form Type EFFECT See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google Add on Google Not now 06/17/2026 - 12:15 AM ⛶ Fullscreen UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Notice of Effectiveness Effectiveness Date: June 16, 2026 Accession Number: 0001193125-26-267506 Submission Type: POS AM CIK: 0001348911 Company Name: KalVista Pharmaceuticals, Inc. File Number: 333-280759 Source: View Original Filing on SEC EDGAR
